We assist organizations in evaluating and optimizing their pharmacy benefit programs to uncover overcharges and secure savings. Leveraging comprehensive auditing techniques and in-depth RFP analysis, we ensure your PBM agreements align with market standards and deliver on their commitments. Our proactive approach empowers you to take control of your pharmacy benefits, reduce costs, and maximize the value of your program.
Quantas Advisors works with the needs of each client. The scope, timeline, and analysis of the RFP can be customized to meet your organization’s specific needs. Our Standard “Best Practices” PBM RFP Submission and Analysis service comprises three phases.
Pre-RFP Analysis
Quantas will provide a Current Market Analysis using recent PBM terms offered for similar-sized employer groups. That Market Analysis will include:
RFP Preparation, Submission & Analysis
PBM Performance Verification
Six months after implementing a new PBM agreement, claims data will be reviewed to ensure the PBM’s performance aligns with contracted terms:
Approximately 9% of the brand drugs dispensed via retail will be going generic in the next five years
Approximately 15% of the brand drugs dispensed via mail service will be going generic in the next five years
Generic fill rate is expected to increase 15–17% in the next five years
PBM strategy is to exclude new generics from discount guarantees
PBMs can “reclassify” new generics as “brands,” to increase discount guarantee